Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
Cell Surface Markers Market is Expected to Reach USD 23.03 Billion Globally in 2019: Transparency Market Research
Transparency Market Research Report Adds "Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents and Kits) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018" to its database. - December 06, 2013 - Transparency Market Research
Announcing New Drug Safety/Pharmacovigilance Training Opportunities
Drug Safety Navigator, LLC will hold numerous live on-line training for those seeking to enhance their knowledge base or may be new to the field. - December 02, 2013 - Drug Safety Navigator, LLC
Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2018
Transparency Market Research Report Adds "Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 – 2018" to its database. - November 24, 2013 - Transparency Market Research
Dr. Emil J. Haldey to Speak Before Medical Society of the State of New York
Dr. Emil J. Haldey, President of New York City-based HALDEY Pharmaceutical Compounding, will speak later this week before an audience of doctors at First District Branch of the Medical Society of the State of New York (MSSNY). MSSNY’s First Branch includes all five boroughs of New York... - November 20, 2013 - HALDEY Pharmaceutical Compounding
Herrmann International and Purdue Pharma Share Tips for Improving Sales by Getting Inside the Customer’s Head
In a joint webinar now available for on-demand viewing, leaders from Herrmann International and Purdue Pharma provide tips for using thinking preference data and tools to improve sales and customer relationships. - November 16, 2013 - Herrmann International
ICRC-Weyer, Allied Clinical Management Form MEDIS Research Group
The Berlin-based clinical contract research organizations, ICRC-Weyer and Allied Clinical Management, have announced that they have entered into a strategic alliance, as part of the newly founded MEDIS Research Group. - November 16, 2013 - ICRC-Weyer GmbH
Pfizer Selects to Deploy Sales Vision CRM and BookVision CLM on iPad
Pfizer as one of the global leading originators has extended operations with Media-Soft Pharmacentric Solutions. Pfizer has gone live with the global most flexible Bookvision CLM and Sales Vision CRM solution for pharmaceuticals. - November 15, 2013 - Media-soft
Metrics Inc. Founder and President Phil Hodges Retires
Hodges started company in 1994; will serve as director at parent company, Mayne Pharma. - November 14, 2013 - Metrics, Inc.
Rosa’s Derek Bartlett to Present Work on Mechanistic Modeling in Diabetes Drug Design at the AAPS Conference
Dr. Bartlett will discuss the use of modeling to evaluate combination therapies for diabetes, November 13th, 2013 in San Antonio, Texas. - November 13, 2013 - Rosa & Co LLC
Rosa & Co CEO, Dr. Ron Beaver Presents "Systems Pharmacology: First Principles to Effective Practice" in the Plenary Session of the Integrating Pharmacometrics Summit
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, announced that Dr. Ron Beaver, CEO, presented a plenary session talk at the Hanson Wade Integrating Pharmacometrics Summit (October 21st -23rd 2013), Munich, Germany, entitled... - November 13, 2013 - Rosa & Co LLC
Chinese Pharma Performance Slows Further in 2013 Amid Government Crackdowns
The overall trend of Chinese pharma this year shows continued decline of profitability despite sustained relatively high output value and revenue growth. Both hospital drug sales and pharmaceutical retail sales growth are slowing, while western medicine foreign trade remained to grow at a low rate, according to China Pharmaceutical Guide 2013 (8th Edition) from WiCON International Group LLC, the publisher of Pharma China. - November 08, 2013 - WiCON International Group LLC
Showcasing BaseCase at ISPOR Dublin 2013: How to Roll Out a Global Value Proposition to Local Affiliates
At ISPOR this year, BaseCase CEO Gijs Hubben and CTO Diarmuid Glynn showcased the company's app development platform to some of the industry's top executives. Top of the list for discussion was the platforms's unique cloud-based editor that permits companies to roll out a global value proposition to local affiliates. - November 08, 2013 - BaseCase
5 Truths About Oncology Pathways You Need to Know Today! Go "Behind the Scenes" to Learn How Pathways Are Created
Pathways are the new oncology formulary, and their influence is increasingly significant whether you are in clinical development, launch, or growth mode for your product. It is more important than ever for oncology manufacturers to take advantage of opportunities to bolster product position within... - November 06, 2013 - Reimbursement Intelligence
LMM Global Innovations Inc Grants Licensing Rights to FranTech USA for High Technology, Computer-Driven Multiple Drug Dispensing Apparatus
The problem of dispensing multiple drugs for life-saving surgeries and on-going patient treatment has just become easier, quicker, more accurate and productive as a new technology is now available globally. LMM Global Innovations Inc has teamed with Global FranTech Group and its subdivision FranTech USA to market a newly patented multiple drug dispensing technology worldwide. - November 03, 2013 - FranTech USA LLC
ALPCO Expands Product Offering with Addition of Mouse-Specific Flow Cytometry Reagents
Earlier this year, ALPCO began offering flow cytometry reagents and data analysis software. As promised, the company has recently added high quality and affordable mouse reagents to their growing flow cytometry portfolio. Among the 600 new mouse reagents are antibodies for CD3, CD4, CD8 and... - October 29, 2013 - ALPCO
Global Vision Expands Worldwide Presence with the Addition of New Reseller in Malaysia
Global Vision partners with IAM-Wonderware to provide proofreading technologies in Malaysia. - October 23, 2013 - Global Vision
VStock Transfer Congratulates Its Client, Soft Landing Labs, LTD., on Securing DTC Eligibility
Soft Landing Labs, LTD. obtains DTC Eligibility. - October 16, 2013 - Vstock Transfer, LLC
Good News for Drug Delivery Researchers: AbboMax, Inc. Offers a Portfolio of Innovative Liposome Reagents
Liposomes are artificially-prepared vesicles that are made out of the same material as a cell membrane, a lipid bilayer. The liposomes can be filled with different substances and used as vehicles for drug or nutrient delivery. AbboMax offers various innovative liposome reagents with a large number of lipid compositions to support the needs of research organizations involved in liposome drug delivery. - October 16, 2013 - AbboMax, Inc.
AsisChem Launches New Streamlined Website with Improved Product Search and E-Commerce Features
AsisChem, the contract medicinal drug and drug discovery and research company co-located in Waltham, Massachusetts and St. Petersburg Russia, announced today the launch of its new website with searchable product profiles and e-commerce shopping functions. The new design of www.asischem.com greatly... - October 08, 2013 - AsisChem
Rosa’s Toufigh Gordi to Present Models and Their Utility in Drug Development at Target Meeting’s 3rd World Drug Discovery Online Conference
Dr. Toufigh Gordi will discuss the application of modeling at different stages in the drug development process, October 16th, 2013. - October 08, 2013 - Rosa & Co LLC
Activus Solutions to Sponsor the 2013 Revitas Industry Summit: Life Sciences in Philadelphia
Industry event will focus on the complex issues facing pharmaceutical and life sciences companies in contracting, pricing, and compliance - October 02, 2013 - Activus Solutions
HALDEY Pharmaceutical Compounding President to Address Brooklyn Physicians on Oct. 2
Dr. Emil J. Haldey will speak before an audience of doctors at the Medical Society of the County of Kings, in association with the Academy of Medicine of Brooklyn. - October 01, 2013 - HALDEY Pharmaceutical Compounding
The Changing Environment for Pharma and Medtech Companies in Europe
SFL Regulatory Affairs Consulting Ltd. (SFL) is pleased to be strengthening its activities in the UK and will be holding an inaugural and networking event in London on 8 October 2013. - September 30, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
Advocates Rally October 1st for a Federal Response to Opioid Epidemic
On October 1, 2013 a national coalition of advocate organizations called the Fed Up! Coalition will hold a major rally to call for an immediate, coordinated and comprehensive federal response to the epidemic of opioid addiction and overdose deaths. The Rally will run from noon until 2:00 p.m. in Upper Senate Park at the Capitol in Washington D.C. - September 28, 2013 - Fed Up Coalition
Canadian Center of Science and Education: How to Get Your Journal Article Published
The Canadian Center of Science and Education offers tips and tools for anyone interested in getting a journal article published. - September 26, 2013 - The Canadian Center of Science and Education
ISPOR Dublin, 2-6 November 2013: Discover BaseCase CLM
At ISPOR Dublin this November BaseCase is presenting BaseCase CLM: a new Closed Loop Marketing product for HEOR and market access teams that enables an improved workflow at the country level. - September 22, 2013 - BaseCase
Pinnacle Ozone Releases the World’s Most Energy Efficient Ozone Generator Technology
Pinnacle Ozone Solutions, LLC announces the release of its newest QuadBlock® Generation II (Gen II) ozone technology. The event marks the introduction of the world’s most advanced and reliable ozone generation system, offering customers substantially lower total energy costs, and lower... - September 20, 2013 - Pinnacle Ozone Solutions, LLC
SignaBlok Achieves Key in Vivo Proof of Concept for Treatment of Cancer and Sepsis
Novel First-in-Class Peptide Inhibitor of TREM-1 Modulates the Inflammatory Response and Shows Promise for Treatment of Cancer and Sepsis - September 18, 2013 - SignaBlok, Inc.
International Polymer Solutions Debuts Corporate Video
Video provides overview of company products and services. - September 16, 2013 - International Polymer Solutions Inc.
Eighth Annual FDA Inspections Summit: Early Bird Registration Ends Sept. 20
Eighth Annual FDA Inspections Summit; New Powers, New Enforcement Posture, New Challenges; Presented by FDAnews; Oct. 23-25, 2013 – Bethesda, MD; www.fdanews.com/FDAInspectionsSummitPR2. - September 15, 2013 - FDAnews
Elsa Gomez Has Recently Been Recognized by The Global Directory of Who's Who Publication
Elsa Gomez, of Corona, California, has recently been recognized by The Global Directory of Who's Who for outstanding contributions and achievements in the field of Pharmaceutical. About Elsa Gomez Elsa Gomez, is the first female director of quality for a pharmaceutical company in Puerto Rico back... - September 15, 2013 - Global Directory of Who's Who
Healthcare Companies Benefit from NAFA's International Fleet Academy
Many of the world's leading pharmaceutical companies are sending their fleet managers to NAFA's International Fleet Academy to learn about global fleet management. - September 14, 2013 - NAFA Fleet Management Association
International Polymer Solutions Launches New Website
TEQCOM and BECO websites merge to form new International Polymer Solutions site. - September 12, 2013 - International Polymer Solutions Inc.
Silicon Kinetics® Ramps Commercial Efforts for Affinity Capture-Mass-Spectrometry (AC-MS)
Appoints Jay Smith as CEO and Keith Waddell as VP Business Development - September 12, 2013 - Silicon Kinetics
LUZ Establishes Linguistic Validation Business Unit
Life science translation provider builds expert team to support patient-reported outcome measures. - September 11, 2013 - LUZ, Inc.
FDA Accepts Biomedica MC Investigational New Drug Filing for ClotFoam®
ClotFoam is the leading agent of a portfolio of hemostatic products based on its proprietary “CLOT” technology. This next generation of hemostatic sealants funded by NIH and the US Army was originally conceived to control severe hemorrhage without need of compression. Products derived from the Clot technology represent a quantum leap in the treatment of hemorrhage. - September 09, 2013 - Biomedica Management Corporation
Doctor's Best Introduces Best 5-HTP
Doctor's Best has introduced Best 5-HTP into its dietary supplement line. Scott Steinford, president of Doctor's Best, made the announcement. This product is available in 180 vegetarian capsules, each providing 100 milligrams of the amino acid 5-hydroxy-L-tryptophan (5-HTP). - September 05, 2013 - Doctor's Best, Inc.
Frost & Sullivan: Diagnostic and Therapeutic Potential of microRNAs Stimulate Need for More Research Tools
Product innovation and the development of high-qualitative assays are the need of the hour. - September 05, 2013 - Frost & Sullivan
CHI Interviews Janet L. Lathey, Ph.D of Emergent BioSolutions on Optimizing Bioassays for Biologics
Janet L. Lathey, Ph.D., Director, Immunology and Assay Development, BioDefense Division, Emergent BioSolutions sits down with conference producer Samantha Lewis to discuss the biggest challenges to managing bioassay variability, new tools and strategies that researchers are using to combat it, and... - August 26, 2013 - Cambridge Healthtech Institute
Recession and Contradiction in the Pharmaceutical Industry in 2013
New report highlights the contradiction at the heart of the pharmaceutical industry in 2013. “Whilst there is increased investment and growth an underlying uncertainty and volatility in the pharmaceutical industry has made investors cautious.” -Pharma IQ Recession Report. - August 22, 2013 - IQPC
BaseCase Launches Closed Loop Marketing for Market Access
Value communication and technology firm BaseCase have announced the launch this week of their closed loop marketing (CLM) solution for market access. - August 22, 2013 - BaseCase
iBeta Completes DEA EPCS Biometric Certification for Lumidigm’s V-Series Fingerprint Devices
iBeta Quality Assurance (“iBeta”), a National Voluntary Laboratory Accreditation Program (NVLAP) accredited Biometrics Testing Laboratory, and DEA-approved EPCS Biometric Certification Lab has completed one of the first DEA EPCS biometric certifications for a series of fingerprint... - August 13, 2013 - iBeta Quality Assurance
FDAnews Webinar — Cosmetics Warning Letters Detail Rash of Problems; Webinar Provides Solutions
Is It a Cosmetic, a Drug or Both? 15-Year Regulatory Veteran Shares Compliance Secrets Presented by FDAnews Aug. 23, 2013 • 1:30 p.m. – 3:00 p.m. EDT http://www.fdanews.com/CosmeticsWebinarPR2 - August 11, 2013 - FDAnews
Innovus Launches New Corporate Website
Innovus Pharmaceuticals, Inc., ("Innovus Pharma") www.innovuspharma.com (OTC: BB: INNV) announced today it has launched a newly designed corporate website. The new website reflects the values and mission of the company and contains updated content on our current product portfolio and... - August 08, 2013 - Innovus Pharmaceuticals, Inc.
G-Mycin Studio LLC launches PortScript App for Independent Pharmacies Patients
Independent pharmacies customers now have easy access to their pharmacies with the launch of PortScript App. - August 07, 2013 - G-Mycin Studio LLC
New Exchangeable Turbine Flow Sensor Ideal for Low Flow Pharmaceutical and Industrial Applications
Clark Solutions’ PFAD Disposable Turbine Flow Sensor is designed for applications with flow rates of .06 lpm to 20 lpm, accuracy 1% of reading. PFAD Flow Sensors feature an easy-to-replace, ultra-lightweight turbine assembly. - August 06, 2013 - Clark Solutions
Dataline Launches Web Based Solution for Clinical Trials
Novo Nordisk is a world leader in diabetes care and continuously carries out clinical research programmes in its endeavour to develop new and effective treatments. These programmes currently involve over 2,000 UK diabetes patients - volunteers - in clinical trials every year at around 100 UK study... - August 02, 2013 - Dataline Software
AveXis Inc. Names Chief Scientific Officer
AveXis Inc. (avexisinc.com), a synthetic biology platform company focused on research and development of technology for disease treatment, today announced Dr. Allan A. Kaspar will serve as the company’s first Chief Scientific Officer (CSO). Dr. Kaspar has held research positions at multiple... - August 01, 2013 - AveXis Inc.
Final Agenda Announced for CHI’s FAST: Functional Analysis & Screening Technologies Congress
Headlined by Karen Burg, DL Taylor, Steve Ludbrook and Aaron Morris, CHI's FAST Congress features three days of innovative presentations for more accurate biological response in drug discovery through novel screening technologies and strategies. - July 27, 2013 - Cambridge Healthtech Institute
ICRC-Weyer to Expand Pharmacovigilance Services for Mid-Sized Pharma Companies
ICRC-Weyer GmbH, a Berlin-based clinical contract research organization, is expanding its pharmacovigilance services for small to mid-sized pharmaceutical companies. - July 24, 2013 - ICRC-Weyer GmbH